stockportfolio.pro
Moderna, Inc. Net Income 2016–2025
Moderna, Inc. (MRNA) annual net income by fiscal year, computed from SEC filings.
| Fiscal year | Net Income | Net margin | Change (YoY) |
|---|---|---|---|
| FY 2025 | $-2.82B | -145.2% | +20.8% |
| FY 2024 | $-3.56B | -110.0% | +24.5% |
| FY 2023 | $-4.71B | -68.8% | -156.4% |
| FY 2022 | $8.36B | 43.4% | -31.5% |
| FY 2021 | $12.20B | 66.1% | +1733.5% |
| FY 2020 | $-747.00M | -93.0% | -45.3% |
| FY 2019 | $-514.00M | -856.7% | -33.6% |
| FY 2018 | $-384.73M | -284.8% | -50.3% |
| FY 2017 | $-255.92M | -124.3% | -18.4% |
| FY 2016 | $-216.21M | -199.5% | — |
Source: Moderna, Inc. SEC filings — income statement (10-K). Refreshed nightly.
See the full picture for Moderna, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeModerna, Inc. — frequently asked questions
What is Moderna, Inc.'s net income?
Moderna, Inc. (MRNA) reported net income of $-2.82B for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from Moderna, Inc.'s official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.